Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer.
Saved in:
| Title: | Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer. |
|---|---|
| Authors: | Ahangar M; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran., Mischak H; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany., Moulavasilis N; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Stravodimos K; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Mahjoubi F; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran., Jankowski J; Institute For Molecular Cardiovascular Research, RWTH Aachen University Hospital, Aachen, Germany., Frantzi M; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany., Vlahou A; Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. |
| Source: | Proteomics [Proteomics] 2026 Jul; Vol. 26 (7), pp. 169-180. Date of Electronic Publication: 2026 Apr 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101092707 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1615-9861 (Electronic) Linking ISSN: 16159853 NLM ISO Abbreviation: Proteomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42046269 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ahangar+M%22">Ahangar M</searchLink>; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Mischak+H%22">Mischak H</searchLink>; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Moulavasilis+N%22">Moulavasilis N</searchLink>; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Stravodimos+K%22">Stravodimos K</searchLink>; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Mahjoubi+F%22">Mahjoubi F</searchLink>; Department of Clinical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Jankowski+J%22">Jankowski J</searchLink>; Institute For Molecular Cardiovascular Research, RWTH Aachen University Hospital, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Frantzi+M%22">Frantzi M</searchLink>; Department of Biomarker Research, Mosaiques Diagnostics GmbH, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Vlahou+A%22">Vlahou A</searchLink>; Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101092707%22">Proteomics</searchLink> [Proteomics] 2026 Jul; Vol. 26 (7), pp. 169-180. <i>Date of Electronic Publication: </i>2026 Apr 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH%22">Wiley-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101092707 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1615-9861 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216159853%22">16159853 </searchLink><i>NLM ISO Abbreviation: </i>Proteomics <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42046269 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/pmic.70135 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 169 Titles: – TitleFull: Urinary Peptidomic Signatures Predict Overall and Progression-Free Survival in Bladder Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ahangar M – PersonEntity: Name: NameFull: Mischak H – PersonEntity: Name: NameFull: Moulavasilis N – PersonEntity: Name: NameFull: Stravodimos K – PersonEntity: Name: NameFull: Mahjoubi F – PersonEntity: Name: NameFull: Jankowski J – PersonEntity: Name: NameFull: Frantzi M – PersonEntity: Name: NameFull: Vlahou A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1615-9861 Numbering: – Type: volume Value: 26 – Type: issue Value: 7 Titles: – TitleFull: Proteomics Type: main |
| ResultId | 1 |